A Cut-off Value Study of N-terminal Brain Natriuretic Peptide （Chemiluminescence Method） (NCT06691477) | Clinical Trial Compass
CompletedNot Applicable
A Cut-off Value Study of N-terminal Brain Natriuretic Peptide （Chemiluminescence Method）
China1,104 participantsStarted 2023-04-10
Plain-language summary
The aim of the study is to evaluate diagnostic performance of N-terminal Brain natriuretic Peptide (NT-proBNP) in acute heart failure among Chinese population. Further, it sought to explore the optimal cut-off point fitting Chinese patients.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age: ≥ 18 years old to voluntarily participate in this study and sign the informed consent form.
* Subjects Remaining serum or plasma sample size \> 500 ml.
* Have symptoms that would make the investigator suspect that they are related to heart failure.
Dyspneic patients presenting to 3 EDs in China were enrolled and had sufficient blood for subsequent NT-proBNP measurement.
Exclusion Criteria:
* Chronic kidney disease stage 4 or 5.
* Chronic renal dialysis.
* Participation in clinical studies that may interfere with participation in this study;
* Any behavior that would increase the subject's risk or prevent the subject from fully complying with or completing this study;
* The sample size is not enough for testing;
* Hemolysis, lipidemia or jaundice may be visible to the naked eye in the sample.